Literature DB >> 25297920

Chromogranin A: a paradoxical player in angiogenesis and vascular biology.

Karen B Helle1, Angelo Corti.   

Abstract

Half a century after the discovery of chromogranin A as a secreted product of the catecholamine storage granules in the bovine adrenal medulla, the physiological role for the circulating pool of this protein has been recently coined, namely as an important player in vascular homeostasis. While the circulating chromogranin A since 1984 has proved to be a significant and useful marker of a wide range of pathophysiological and pathological conditions involving the diffuse neuroendocrine system, this protein has now been assigned a physiological "raison d'etre" as a regulator in vascular homeostasis. Moreover, chromogranin A processing in response to tissue damage and blood coagulation provides the first indication of a difference in time frame of the regulation of angiogenesis evoked by the intact chromogranin A and its two major peptide products, vasostatin-1 and catestatin. The impact of these discoveries on vascular homeostasis, angiogenesis, cancer, tissue repair and cardio-regulation will be discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25297920     DOI: 10.1007/s00018-014-1750-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  69 in total

Review 1.  Alphavbeta6 integrin in wound healing and cancer of the oral cavity.

Authors:  G J Thomas; M L Nyström; J F Marshall
Journal:  J Oral Pathol Med       Date:  2006-01       Impact factor: 4.253

2.  The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.

Authors:  Anna Blois; Boleslaw Srebro; Maurizio Mandalà; Angelo Corti; Karen B Helle; Guldborg Serck-Hanssen
Journal:  Regul Pept       Date:  2006-05-24

3.  Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues.

Authors:  A Iacangelo; H U Affolter; L E Eiden; E Herbert; M Grimes
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

4.  Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.

Authors:  M H Metz-Boutigue; P Garcia-Sablone; R Hogue-Angeletti; D Aunis
Journal:  Eur J Biochem       Date:  1993-10-01

5.  Plasma levels and potential roles of catestatin in patients with coronary heart disease.

Authors:  Lin Liu; Wenhui Ding; Feng Zhao; Libin Shi; Yongzheng Pang; Chaoshu Tang
Journal:  Scand Cardiovasc J       Date:  2013-05-20       Impact factor: 1.589

6.  The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism.

Authors:  Tommaso Angelone; Anna Maria Quintieri; Bhawanjit K Brar; Pauline T Limchaiyawat; Bruno Tota; Sushil K Mahata; Maria Carmela Cerra
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

7.  Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Silvia Capellino; Torsten Lowin; Peter Angele; Werner Falk; Joachim Grifka; Rainer H Straub
Journal:  J Rheumatol       Date:  2007-12-01       Impact factor: 4.666

8.  The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration.

Authors:  Daniela Belloni; Silvia Scabini; Chiara Foglieni; Lorenzo Veschini; Alessio Giazzon; Barbara Colombo; Alessandro Fulgenzi; Karen B Helle; Maria Elena Ferrero; Angelo Corti; Elisabetta Ferrero
Journal:  FASEB J       Date:  2007-06-12       Impact factor: 5.191

9.  Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanism.

Authors:  Sandra Cappello; Tommaso Angelone; Bruno Tota; Pasquale Pagliaro; Claudia Penna; Raffaella Rastaldo; Angelo Corti; Gianni Losano; Maria Carmela Cerra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-06       Impact factor: 4.733

10.  Prognostic value of circulating chromogranin A levels in acute coronary syndromes.

Authors:  Anna M Jansson; Helge Røsjø; Torbjørn Omland; Thomas Karlsson; Marianne Hartford; Allan Flyvbjerg; Kenneth Caidahl
Journal:  Eur Heart J       Date:  2008-11-21       Impact factor: 29.983

View more
  20 in total

Review 1.  Chromogranins: from discovery to current times.

Authors:  Karen B Helle; Marie-Helene Metz-Boutigue; Maria Carmela Cerra; Tommaso Angelone
Journal:  Pflugers Arch       Date:  2017-09-05       Impact factor: 3.657

Review 2.  Ligandomics: a paradigm shift in biological drug discovery.

Authors:  Wei Li; Iok-Hou Pang; Mario Thiego F Pacheco; Hong Tian
Journal:  Drug Discov Today       Date:  2018-01-08       Impact factor: 7.851

3.  "Unclassical" Combination of Smell Dysfunction, Altered Abdominal Nociception and Human Hypertension Associated "Classical" Adrenal-Augmentation.

Authors:  Daniel S Leon-Ariza; Juan S Leon-Ariza; Fidias E Leon-Sarmiento
Journal:  J Med Cases       Date:  2015-11-01

4.  Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization.

Authors:  Liyang Ji; Prabuddha Waduge; Wencui Wan; Hong Tian; Jin Li; Jinsong Zhang; Rui Chen; Wei Li
Journal:  FEBS J       Date:  2022-02-01       Impact factor: 5.622

5.  Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease.

Authors:  Elisabetta Ferrero; Angelo Corti; Julien Haroche; Daniela Belloni; Barbara Colombo; Alvise Berti; Giulio Cavalli; Corrado Campochiaro; Antonello Villa; Fleur Cohen-Aubart; Zahir Amoura; Claudio Doglioni; Lorenzo Dagna; Marina Ferrarini
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

Review 6.  Secretogranin III: a diabetic retinopathy-selective angiogenic factor.

Authors:  Wei Li; Keith A Webster; Michelle E LeBlanc; Hong Tian
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

7.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.

Authors:  Stefano Tarantini; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Peter Toth; Tripti Gautam; Cory B Giles; Praveen Ballabh; Jeanne Y Wei; Jonathan D Wren; Nicole M Ashpole; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-09-09

8.  Secretogranin III promotes angiogenesis through MEK/ERK signaling pathway.

Authors:  Fen Tang; Mario Thiego F Pacheco; Ping Chen; Dan Liang; Wei Li
Journal:  Biochem Biophys Res Commun       Date:  2017-11-14       Impact factor: 3.575

9.  Catestatin reverses the hypertrophic effects of norepinephrine in H9c2 cardiac myoblasts by modulating the adrenergic signaling.

Authors:  Md Jahangir Alam; Richa Gupta; Nitish R Mahapatra; Shyamal K Goswami
Journal:  Mol Cell Biochem       Date:  2019-12-02       Impact factor: 3.396

Review 10.  Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.

Authors:  Angelo Corti; Fabrizio Marcucci; Tiziana Bachetti
Journal:  Pflugers Arch       Date:  2017-10-10       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.